Reply to: Towards causal validation and clinical translation of the PAK2–fibroblast axis in idiopathic pulmonary fibrosis
European Respiratory Journal · 2026-03 · 67 (3) · 2502353
DOI: 10.1183/13993003.02353-2025 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Respiratory Journal, online erschienen am 19.03.2026. Verfasst von Yuta Hirano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan. Die Arbeit nennt 10 Literaturangaben. Gefördert von: EVerMed Inc., Japan Society for the Promotion of Science, Mochida Memorial Foundation for Medical and Pharmaceutical Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
- Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan.
- These authors contributed equally to this work.
- Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan yuugot@jikei.ac.jp.
- Division of Next-generation Drug Development Research, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan.
ORCID-Profile: Masahiro Yoshida
Förderung
- EVerMed Inc.
- Japan Society for the Promotion of Science
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- GlaxoSmithKline Japan
- Japanese Respiratory Society
Zitieren
APA
Hirano, Y., Yoshida, M., Watanabe, N., Araya, J., Yamamoto, Y., & Fujita, Y. (2026). Reply to: Towards causal validation and clinical translation of the PAK2–fibroblast axis in idiopathic pulmonary fibrosis. European Respiratory Journal, 67(3), 2502353. https://doi.org/10.1183/13993003.02353-2025
Vancouver
Hirano Y, Yoshida M, Watanabe N, Araya J, Yamamoto Y, Fujita Y. Reply to: Towards causal validation and clinical translation of the PAK2–fibroblast axis in idiopathic pulmonary fibrosis. European Respiratory Journal. 2026;67(3):2502353. doi:10.1183/13993003.02353-2025
BibTeX
@article{Hirano2026,
author = {Hirano, Yuta and Yoshida, Masahiro and Watanabe, Naoaki and Araya, Jun and Yamamoto, Yusuke and Fujita, Yu},
title = {Reply to: Towards causal validation and clinical translation of the PAK2–fibroblast axis in idiopathic pulmonary fibrosis},
journal = {European Respiratory Journal},
year = {2026},
volume = {67},
number = {3},
pages = {2502353},
doi = {10.1183/13993003.02353-2025}
}
EUVIMED